Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Phospho-OPRM1 (Ser377) Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5105163
Description
Antibody detects endogenous levels of OPRM1 only when phosphorylated at Ser377, which site historically referenced as Ser375.
The OPRM1 gene encodes the mu opioid receptor, which is the primary site of action for the most commonly used opioids, including morphine, heroin, fentanyl, and methadone. It is also the primary receptor for endogenous opioid peptides beta-endorphin and the enkephalins. The OPRM1 receptor is a membrane of the G protein-coupled receptor family. There are at least 3 types of opioid receptors, mu, kappa, and delta, each with a distinct pharmacologic profile.
Specifications
Phospho-OPRM1 (Ser377) | |
Polyclonal | |
Unconjugated | |
OPRM1 | |
hMOP; KIAA0403; LMOR; MOP; MOP receptor; MOP-R; Mor; MOR1; M-OR-1; MOR-1; MOR-1C; MOR-1O; MORA; Mu opiate receptor; mu opioid receptor; mu opioid receptor hMOR-1a; mu opioid receptor splice variant mMOR-1Z; mu opioid receptor splice variant rMOR-1S; mu opioid receptor splice variant rMOR-1Z; mu-opioid receptor; muOR; MUOR1; mu-type opioid receptor; Opioid mu receptor; Opioid Receptor; opioid receptor B; opioid receptor mu 1; opioid receptor, mu 1; OPRM; Oprm1; Oprrm1; OTTHUMP00000017463; Ror-b | |
Rabbit | |
Sequential chromatography | |
RUO | |
18390, 4988 | |
-20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
P35372, P42866 | |
OPRM1 | |
A synthesized peptide derived from human OPRM1(Accession P35372), corresponding to amino acid residues around phosphorylated Ser377. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction